Discover open access scientific publications

Search, annotate, share and cite publications

Publications by R. Palmero

P1.13-29 Overall Response Rate of Nintedanib and Docetaxel in Combination With the Nutraceutical Use of Silibinin in Advanced NSCLC

Journal of Thoracic Oncology

Respiratory Medicine

English

P2.03-02 Cell-Free DNA (cfDNA) Testing in Lung Adenocarcinoma (LUAC) Patients: Spanish Lung Liquid Versus Invasive Biopsy Program (SLLIP)

Journal of Thoracic Oncology

Respiratory Medicine

English

Related publications

Focus on Nintedanib in NSCLC and Other Tumors

Frontiers in Medicine

English

P1.13-11 PRO-CTCAE Toxicities in Advanced NSCLC Patients With EGFR Mutations: A Real World Assessment

Journal of Thoracic Oncology

Respiratory Medicine

English

P3.01-44 CYFRA 21-1 as a Predictor to Response to Chemotherapy and Overall Survival in Patients With Advanced NSCLC

Journal of Thoracic Oncology

Respiratory Medicine

English

Afatinib in Advanced NSCLC: A Profile of Its Use

Drugs and Therapy Perspectives

English

Role of KRAS-LCS6 Polymorphism in Advanced NSCLC Patients Treated With Erlotinib or Docetaxel in Second Line Treatment (TAILOR)

Scientific Reports

Multidisciplinary

English

P080 Efficacy and Safety of Docetaxel Plus Ramucirumab: A Consecutive Analysis of 68 Patients With Advanced NSCLC

Journal of Thoracic Oncology

Respiratory Medicine

English

Efficacy and Safety of Nintedanib in Patients With Advanced Idiopathic Pulmonary Fibrosis

BMC Pulmonary Medicine

Respiratory Medicine

English

P1.13-18 Exploring the Resistance Mechanism of Osimertinib and Monitoring the Treatment Response Using Plasma ctDNA in Chinese NSCLC Patients

Journal of Thoracic Oncology

Respiratory Medicine

English

MA10.05 Effect of Early Steroids Use in Advanced NSCLC Patients Treated With Immunotherapy

Journal of Thoracic Oncology

Respiratory Medicine

English